Thema
Journal Article
1.291
Comment
860
Antibodies, Monoclonal, Humanized
779
Letter
779
Research Support, Non-U.S. Gov't
765
Antibodies, Monoclonal
451
Randomized Controlled Trial
376
Multicenter Study
337
Case Reports
280
Research Support, N.I.H., Extramural
252
EC 2.7.10.1
250
Editorial
239
Clinical Trial, Phase III
199
Antineoplastic Agents
192
Comparative Study
135
Research Support, U.S. Gov't, P.H.S.
122
Clinical Trial, Phase II
98
EC 2.7.11.1
92
Receptor, ErbB-2
85
DPT0O3T46P
79
pembrolizumab
79
Bevacizumab
72
EC 2.7.10.2
72
2S9ZZM9Q9V
71
Biomarkers
71
Klinische Studie
71
Protein Kinase Inhibitors
70
Review
68
Clinical Trial, Phase I
65
DNA-Binding Proteins
64
Proto-Oncogene Proteins
64
Membrane Proteins
63
ErbB Receptors
59
GENETICS, HUMAN
59
Human immunodeficiency virus--HIV
58
Immunosuppressive Agents
57
Carrier Proteins
55
RNA, Messenger
55
Proteins
54
Clinical Conference
53
Pyrazoles
53
Cetuximab
52
Glucocorticoids
52
PQX0D8J21J
52
Trastuzumab
52
Angiogenesis Inhibitors
51
P188ANX8CK
51
Nuclear Proteins
50
Programmed Cell Death 1 Receptor
50
Pyrimidines
48
mehr ...